Evidence for an increased fatty acid utilization in platelets in diabetes mellitus: its correlation with platelet hyperfunction
Musso, R.; Cacciola, R.R.; Giustolisi, R.; Cacciola, E.
Progress in Clinical and Biological Research 283: 513-518
1988
ISSN/ISBN: 0361-7742 PMID: 3211959 Document Number: 324444
Document emailed within 1 workday
Related Documents
Thomas-Benhamou, G.; Rayssiguier, Y.; Cardot, P.; Gueux, E.; Trugnan, G. 1988: Magnesium deprivation or short-term essential fatty acid deficiency in rats: effects on serum lipids, platelet fatty acid composition and arachidonic acid incorporation into platelet phospholipids Magnesium Research 1(1-2): 39-44Rao, A.K.; Goldberg, R.E.; Walsh, P.N. 1984: Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume Journal of Laboratory and Clinical Medicine 103(1): 82-92
Zhu, Q.-q.; Lou, D.-j.; Si, X.-w.; Guan, L.-l.; You, Q.-y.; Yu, Z.-m.; Zhang, A.-z.; Li, D. 2010: Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease Zhonghua Nei Ke Za Zhi 49(4): 305-308
Nakashima, N.; Umeda, F.; Yamauchi, T.; Ishii, H.; Hisatomi, A.; Nawata, H.; Masuko, H.; Nakayama, K.; Tatematsu, A. 1992: Platelet-derived growth factor and growth-promoting activity in the serum samples and platelets of patients with non-insulin-dependent diabetes mellitus Journal of Laboratory and Clinical Medicine 120(1): 78-85
Kolb, E. 1982: Current findings on the regulation of fatty acid degradation as well as production and utilization of ketone bodies with special reference to the importance of carnitine in fatty acid metabolism Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(24): 821-829
Knudtzon, J.; Dahl-Jørgensen, K.; Meen, H.D.; Baevre, H.; Søvik, O. 1983: Children and adolescents with diabetes mellitus. Understanding correlation between glycosylated hemoglobin and diabetes mellitus and its management Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 103(5): 516-518
De Luis, D.A.; Gonzalez Sagrado, M.; Aller, R.; Izaola, O.; Conde, R.; De la Fuente, B. 2010: Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on insulin resistance and adipocytokines in patients with diabetes mellitus type 2 European Review for Medical and Pharmacological Sciences 14(2): 89-95
Galenok, V.A.; Dikker, V.E.; Gostinskaia, E.V.; Zykov, A.A.; Khanykina, I.V. 1991: Free fatty acid spectrum and rheological properties of erythrocytes in people with disturbed glucose tolerance and in patients with diabetes mellitus Problemy Endokrinologii 37(2): 17-20
Jain, S.; Gaiha, M.; Bhattacharjee, J.; Anuradha, S. 2002: Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study Journal of the Association of Physicians of India 50: 1028-1033
González-Sicilia de Llamas, L.; Lafuente López-Herrera, M.; Muñoz Sánchez, J.A.; Martínez Marín, A.; Fernández Pardo, J.; Espi Martínez, F. 1990: Evidence of abnormal kidney processing of uric acid in patients with insulin-dependent diabetes mellitus Revista Clinica Espanola 186(4): 159-162
Weiss, R.; Bazalo, G.; Clark, N.; Forma, F.; Ingram, G.; Alemayehu, B. 2007: Correlation of HEDIS diabetes health plan score with utilization of diabetes medications Managed Care Interface 20(10): 14-17
Spector, A.A.; Imig, B. 1971: Effect of free fatty acid concentration on the transport and utilization of other albumin-bound compounds: hydroxyphenylazobenzoic acid Molecular Pharmacology 7(5): 511-518
Perusicová, J.; Neuwirt, K. 1993: The Prague Diabetes Registry--computer utilization. 2. Body mass index, family history, manifestation of diabetes mellitus Casopis Lekaru Ceskych 132(3): 74-77
Colwell, J.A.; Halushka, P.V. 1982: Platelets, prostaglandins, and coagulation in diabetes mellitus Mount Sinai Journal of Medicine new York 49(3): 215-222
Mcgregor, L.; Renaud, S. 1978: Effect of dietary linoleic acid deficiency on platelet aggregation and phospholipid fatty acid of rats Thrombosis Research 12(5): 921-927
Yamazaki, H.; Motomiya, T.; Yahara, Y.; Onozawa, Y. 1981: Hyperfunction of platelets Rinsho Byori. Japanese Journal of Clinical Pathology 29(4): 350-357
Chirkov, I.I.; Tyshchiuk, I.A.; Severina, I.S.; Starosel'tseva, L.K. 1990: ADP-induced aggregation of human platelets in diabetes mellitus Voprosy Meditsinskoi Khimii 36(4): 20-22
Decraene, T.; Vandewalle, C.; Pipeleers, D.; Gorus, F.K. 1992: Increased concentrations of total IgM at clinical onset of type 1 (insulin-dependent) diabetes: correlation with IgM binding to cells. the Belgian Diabetes Registry Clinical Chemistry 38(9): 1762-1767
Dmoszyńska-Giannopoulou, A.; Roliński, J.; Sokołowska, B.; Nowakowski, A. 1989: Effect of vitamin e on the function of blood platelets in patients with diabetes mellitus Polski Tygodnik Lekarski 44(21-22): 496-498
Dobrev, D.; Terzieva, T.; Krŭstev, I.; Svinarov, D.; Petrova, V. 1988: Fatty acids in diabetes mellitus Vutreshni Bolesti 27(6): 31-35